Chapter 12. Bioterrorism

  1. Rolf Ekman3,
  2. Jerzy Silberring4,
  3. Ann Westman-Brinkmalm3 and
  4. Agnieszka Kraj4
  1. Vito G. Delvecchio1 and
  2. Cesar V. Mujer2

Published Online: 26 MAR 2008

DOI: 10.1002/9780470395813.ch12

Mass Spectrometry: Instrumentation, Interpretation, and Applications

Mass Spectrometry: Instrumentation, Interpretation, and Applications

How to Cite

Delvecchio, V. G. and Mujer, C. V. (2008) Bioterrorism, in Mass Spectrometry: Instrumentation, Interpretation, and Applications (eds R. Ekman, J. Silberring, A. Westman-Brinkmalm and A. Kraj), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470395813.ch12

Editor Information

  1. 3

    Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Molndal, Sweden

  2. 4

    Poland Faculty of Chemistry and Regional Laboratory, Jagiellonian University, Krakow, Poland

Author Information

  1. 1

    Vital Probes Inc., Mayfield, Pennsylvania, USA

  2. 2

    Calvert Laboratories, Olyphant, Pennsylvania, USA

Publication History

  1. Published Online: 26 MAR 2008
  2. Published Print: 21 NOV 2008

Book Series:

  1. Wiley-Interscience Series in Mass Spectrometry

Book Series Editors:

  1. Dominic M. Desiderio5,6 and
  2. Nico M. M. Nibbering7

Series Editor Information

  1. 5

    Departments of Neurology and Biochemistry, USA

  2. 6

    University of Tennessee Health Science Center, USA

  3. 7

    Vrije Universiteit Amsterdam, The Netherlands

ISBN Information

Print ISBN: 9780471713951

Online ISBN: 9780470395813

SEARCH

Keywords:

  • bioterrorism and pathogenic microorganisms or toxin intentional use;
  • bioterrorist events and biological threat agents;
  • immunoproteomics and immunogenic protein identification

Summary

This chapter contains sections titled:

  • What is Bioterrorism?

  • Some Historical Accounts of Bioterrorism

  • Geneva Protocol of 1925 and Biological Weapons Convention of 1972

  • Categories of Biothreat Agents

  • Challenges

  • MS Identification of Biomarker Proteins

  • Development of New Therapeutics and Vaccines Using Immunoproteomics

  • References